Latest News
Bio2013 KODE Biotech Presentation
The attached file is the KODE Biotech company presentation given at Bio2103 (Chicago) KODE Biotech Ltd is the licensor of the simplest and most rapid biosurface modification platform available today...
FSL-PEG pegylation of virus extends blood circulation
In this paper the team of Dr Stephen Russell at Mayo Clinic (Rochester) used FSL-PEG to modify VSV. When injected into mice they were able to demonstrate these PEGylated viruses had extended circulatory half-life in the presence of anti-VSV antibodies...
New KODE technology video
We are proud to show off our new video that gives an overview of how KODE technology works. This excellent 3D rendering was done by the guys over at Seamonkey Media The video is available at http://www.youtube.com/watch?v=U14EnuNyJZc and also is embedded on our home page.
3/20 - One platform, numerous advantages
4/20 - The architecture of a KODE(™) Function-Spacer-Lipid (FSL) construct is analogous to a flower with three structural components.
5/20 - Gain ability to use non surface attaching molecules or non binding surfaces and increase sensitivity and specificity
6/20 - In solution the amphipathic FSL will form as micelles
7/20 - Spontaneous insertion into lipid membranes occurs by simple contact
8/20 - FSLs can label hydrophobic and hydrophilic surfaces
9/20 - Optimization through spacer and lipid options
10/20 - Flexible FSL design options
11/20 - A diverse range of functional heads exist
12/20 - The spacer design is critical to functionality
13/20 - The lipid tail induces amphipathic characteristics to the construct
14/20 - Simplest and most rapid biosurface modification technology available
15/20 - Modify almost any surface without a loss in vitality
16/20 - Multiple applications and opportunities
17/20 - Widest application range of any technology
18/20 - Available off-the-shelf or custom-built
19/20 - KODE is seeking new partnerships and licensees
